Difficulty: Medium
Average Score: 78%
Practice
A 31-year-old woman presents to the clinic for follow-up of her abdominal pain. The pain has been occurring for a couple of years but has worsened recently. She is often constipated and then will have periods of diarrhea. Her pain does usually improve after a bowel movement. After multiple negative tests, the diagnosis of constipation-predominant irritable bowel syndrome is made. Which of the following is an appropriate treatment for this patient?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Sodium bicarbonate. Sodium bicarbonate is used as a treatment for irritable bowel syndrome (IBS) with constipation due to its ability to neutralize stomach acid and relieve symptoms such as abdominal pain and discomfort. It helps to regulate the pH levels in the gastrointestinal tract, potentially reducing the severity of symptoms like constipation and diarrhea.
Option A) Infliximab is a medication used to treat inflammatory conditions like Crohn's disease or rheumatoid arthritis, not typically indicated for IBS.
Option B) Metoclopramide is a prokinetic agent that increases muscle contractions in the upper digestive tract, mainly used for conditions like gastroesophageal reflux disease (GERD) or gastroparesis, not a primary treatment for IBS.
Option C) Ondansetron is an antiemetic mainly used to control nausea and vomiting, not a direct treatment for IBS symptoms.
Educationally, understanding the rationale behind each treatment option is crucial for healthcare providers to make informed decisions based on the patient's specific condition and needs. It also highlights the importance of differentiating between various medications and their indications to ensure safe and effective patient care.
Option A) Infliximab is a medication used to treat inflammatory conditions like Crohn's disease or rheumatoid arthritis, not typically indicated for IBS.
Option B) Metoclopramide is a prokinetic agent that increases muscle contractions in the upper digestive tract, mainly used for conditions like gastroesophageal reflux disease (GERD) or gastroparesis, not a primary treatment for IBS.
Option C) Ondansetron is an antiemetic mainly used to control nausea and vomiting, not a direct treatment for IBS symptoms.
Educationally, understanding the rationale behind each treatment option is crucial for healthcare providers to make informed decisions based on the patient's specific condition and needs. It also highlights the importance of differentiating between various medications and their indications to ensure safe and effective patient care.